Login / Signup

Preventing recurrent preterm birth with 125 mg of 17-alpha-hydroxyprogesterone caproate.

Fukuda TomaHyo KyozukaTsuyoshi MurataShun YasudaAkiko YamaguchiKeiya Fujimori
Published in: The journal of obstetrics and gynaecology research (2021)
In this study population, weekly IM injections of 125 mg of 17-OHPC reduced the risk of recurrent PTB <37 and <34 weeks' gestation.
Keyphrases
  • preterm birth
  • gestational age
  • low birth weight